AACE Conference Coverage

AACE 2017

Antithyroid Drug Induces Rare, Dangerous Side Effect

By May 11, 2017

"Periodic screening and monitoring of CBC while on treatment is crucial to monitor development of neutropenia which can be totally asymptomatic," the authors concluded.

AACE 2017

Hyperglycemia Despite High Doses of IV Insulin: An Administration Error?

By May 09, 2017

An interaction check showed that norepinephrine is not compatible with insulin in the same line as it renders the insulin ineffective.

AACE 2017

Hypoglycemia Rate, A1c Goals Compared for Basal Insulin Switches

By May 06, 2017

Switching basal insulins to GLA-300 vs. other basal insulins showed similarly improved glycemic cotrol but with significantly lower risk of hypoglycemia.

AACE 2017

ALT, AST Changes Linked to Glucose Parameters Changes in Tesamorelin-Treated Patients

By May 06, 2017

Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone.

AACE 2017

Switching to Insulin Glargine U300 Beneficial in Poorly Controlled Diabetes

By May 06, 2017

Study patients showed reduced HbA1c and pre-prandial insulin requirements after transitioning to insulin glargine U300.

AACE 2017

How Does Highly Active Antiretroviral Therapy Impact BMI in HIV Patients?

By May 06, 2017

Findings from this review were consistent with other short-term studies that evaluated weight changes post-HAART initiation.

AACE 2017

Significant Improvement in Glycemic Control With Weight Loss Intervention

By May 06, 2017

A retrospective study to assess phentermine and the OPTIFAST diet program on weight and diabetes outcomes at 6 months.

AACE 2017

Weekly vs. Daily Levothyroxine for Hypothyroidism: What's More Effective?

By May 06, 2017

Once-weekly levothyroxine vs. daily levothyroxine proved safe and effective for the treatment of hypothyroidism in non-adherent young and middle-aged adults.

AACE 2017

Brand vs. Generic Levothyroxine: Effect on TSH Lab Data Compared

By May 06, 2017

Synthroid was associated with an 11% lower likelihood of having TSH labs out of range when compared with similar patients taking generic levothyroxine.

AACE 2017

Effect of Vit D Replacement in Patients With Subclinical Hypothyroidism

By May 06, 2017

After 3 months of treatment with vitamin D, the researchers found a significant increase in serum vitamin D as well as significant reductions in TSH to 4.7 and anti TPO titre.